เอกสารอ้างอิง
[1]. สมาคมโรคตับแห่งประเทศไทย. Cirrhosis and complications; 2564. [เข้าถึงเมื่อ 12 พ.ย. 2566]. เข้าถึงได้จาก: https://thasl.org/spontaneous-bacterial-peritonitis/.
[2]. Biggins SW, Angeli P, Garcia TG, Ginès P, Ling SC, Nadim MK, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome. Practice Guidance by the American Association for the Study of Liver Diseases. 2021;74(2):1014-1048. Doi: 10.1002/hep.31884.
[3]. Yim HJ, Suh SJ, Jung YK, Yim SY, Seo YS, Lee YR, et al. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial. American Journal of Gastroenterology 113(8):p 1167-1176, August 2018. Doi: 10.1038/s41395-018-0168-7.
[4]. Wang W, Yang J, Liu C, Song P, Wang W, Xu H, et al. Norfloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifaximin for the prevention of spontaneous bacterial peritonitis: a network meta-analysis. Eur J Gastroenterol Hepatol. 2019; 31(8):905-910. Doi: 10.1097/MEG.0000000000001446.
[5]. Song S, Yang Y, Geng C, Tang Z, Wang C, Li X. Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis. BMC Infect Dis. 2023; 23(1):557. Doi: 10.1186/s12879-023-08557-6.